Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...

There are currently, however, two radioligands that are United States Food and Drug Administration (FDA)-approved for the treatment of mCRPC patients: Patients with advanced prostate cancer are at ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.

Professor Adrian Crellin, 70, noticed blood in his urine and promptly sought medical attention from his GP, leading to a ...

A top UK doctor has been left ‘devastated’ after being diagnosed with an incurable cancer he’s spent his life treating.

[25] The preferential metastatic sites in 316 patients with PC were bone (89.5% ... BM: Brain metastasis; CRPC: Castration-resistant prostate cancer; CT: Computed tomography; NA: Not assessed ...

More men are getting checked for prostate cancer and realising they have the disease at an early stage, but charity Prostate ...

A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...

Results of a study led by the Vall d'Hebron Institute of Oncology (VHIO) support the feasibility of using RAD51 testing to ...

Further tests, such as CT scans and bone scans, may be performed to determine whether prostate cancer has spread. Management strategies for prostate cancer should be guided the severity of the ...